Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646
<b>Figure Legend</b> [...]
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/30/2/334 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832587876870651904 |
|---|---|
| author | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori |
| author_facet | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori |
| author_sort | Chiyuki Awahara |
| collection | DOAJ |
| description | <b>Figure Legend</b> [...] |
| format | Article |
| id | doaj-art-b7046e6f8b574b7c95aa299dbe34b953 |
| institution | Kabale University |
| issn | 1420-3049 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj-art-b7046e6f8b574b7c95aa299dbe34b9532025-01-24T13:43:39ZengMDPI AGMolecules1420-30492025-01-0130233410.3390/molecules30020334Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646Chiyuki Awahara0Daiki Oku1Saki Furuta2Kazuya Kobayashi3Kenta Teruya4Kenichi Akaji5Yasunao Hattori6Department of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanDepartment of Neurochemistry, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai 980-8575, JapanDepartment of Medicinal Chemistry, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, JapanCenter for Instrumental Analysis, Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8412, Japan<b>Figure Legend</b> [...]https://www.mdpi.com/1420-3049/30/2/334n/a |
| spellingShingle | Chiyuki Awahara Daiki Oku Saki Furuta Kazuya Kobayashi Kenta Teruya Kenichi Akaji Yasunao Hattori Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 Molecules n/a |
| title | Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 |
| title_full | Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 |
| title_fullStr | Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 |
| title_full_unstemmed | Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 |
| title_short | Correction: Awahara et al. The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease. <i>Molecules</i> 2022, <i>27</i>, 1646 |
| title_sort | correction awahara et al the effects of side chain configurations of a retro inverso type inhibitor on the human t cell leukemia virus htlv 1 protease i molecules i 2022 i 27 i 1646 |
| topic | n/a |
| url | https://www.mdpi.com/1420-3049/30/2/334 |
| work_keys_str_mv | AT chiyukiawahara correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT daikioku correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT sakifuruta correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT kazuyakobayashi correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT kentateruya correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT kenichiakaji correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 AT yasunaohattori correctionawaharaetaltheeffectsofsidechainconfigurationsofaretroinversotypeinhibitoronthehumantcellleukemiavirushtlv1proteaseimoleculesi2022i27i1646 |